SHANGHAI, China, May 15, 2012 (BUSINESS WIRE) -- The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes(R) initiative to China and India, pledging $15 million over five years to help these developing nations with ... Tue, 15 May 2012 07:01:51 -0700

BMS-564929 is an investigational selective androgen receptor modulator, which is being developed by Bristol-Myers Squibb for treatment of the symptoms of ...

Bristol-Myers Squibb Company (NYSE:BMY) today announced that new data on its approved and investigational oncology compounds will be featured in ten oral presentations at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in ... Wed, 16 May 2012 15:01:37 -0700

Bristol-Myers Squibb (NYSE: BMY), often referred to as BMS, is a pharmaceutical company, headquartered in New York City. The company was formed in 1989, ...

Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients ...